Eli Lilly's Weight-Loss Drug Breakthrough Sparks 13% Stock Surge in Premarket Trading

Eli Lilly and Co. shares surged over 13% in premarket trading following the announcement of positive phase 3 results for its ACHIEVE-1 weight loss drug, marking a significant miles...